123 related articles for article (PubMed ID: 30215733)
1. Novel synthetic polymyxins kill Gram-positive bacteria.
Rudilla H; Pérez-Guillén I; Rabanal F; Sierra JM; Vinuesa T; Viñas M
J Antimicrob Chemother; 2018 Dec; 73(12):3385-3390. PubMed ID: 30215733
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
[No Abstract] [Full Text] [Related]
3. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
6. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
7. Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms.
Jorge P; Grzywacz D; Kamysz W; Lourenço A; Pereira MO
PLoS One; 2017; 12(3):e0174654. PubMed ID: 28355248
[TBL] [Abstract][Full Text] [Related]
8. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB
Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
[TBL] [Abstract][Full Text] [Related]
11. Polymyxin derivatives as broad-spectrum antibiotic agents.
Su M; Wang M; Hong Y; Nimmagadda A; Shen N; Shi Y; Gao R; Zhang E; Cao C; Cai J
Chem Commun (Camb); 2019 Oct; 55(87):13104-13107. PubMed ID: 31612170
[TBL] [Abstract][Full Text] [Related]
12. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
[TBL] [Abstract][Full Text] [Related]
13. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
14. Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).
Knafl D; Tobudic S; Cheng SC; Bellamy DR; Thalhammer F
Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):677-680. PubMed ID: 27896496
[TBL] [Abstract][Full Text] [Related]
15. Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm and intracellular bacteria.
Yang SC; Yen FL; Wang PW; Aljuffali IA; Weng YH; Tseng CH; Fang JY
Future Microbiol; 2017 Sep; 12():1059-1073. PubMed ID: 28799789
[TBL] [Abstract][Full Text] [Related]
16. Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
Khorvash F; Mostafavizadeh K; Mobasherizadeh S
Pak J Biol Sci; 2008 May; 11(9):1282-5. PubMed ID: 18819540
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysis.
Knaack D; Idelevich EA; Schleimer N; Molinaro S; Kriegeskorte A; Peters G; Becker K
Diagn Microbiol Infect Dis; 2019 Apr; 93(4):362-368. PubMed ID: 30554844
[TBL] [Abstract][Full Text] [Related]
18. Effects of colistin on biofilm matrices of Escherichia coli and Staphylococcus aureus.
Klinger-Strobel M; Stein C; Forstner C; Makarewicz O; Pletz MW
Int J Antimicrob Agents; 2017 Apr; 49(4):472-479. PubMed ID: 28267594
[TBL] [Abstract][Full Text] [Related]
19. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
Luther MK; Mermel LA; LaPlante KL
Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
[TBL] [Abstract][Full Text] [Related]
20. MRSA--the tip of the iceberg.
Appelbaum PC
Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
